Analyze Diet

Topic:Pharmaceuticals

Pharmaceuticals in equine medicine encompass a wide range of drugs and therapeutic agents used to treat various conditions in horses. These substances include analgesics, anti-inflammatories, antibiotics, sedatives, and anthelmintics, among others. Each class of pharmaceuticals is designed to address specific health issues, such as pain management, infection control, or parasitic infestations. The pharmacokinetics and pharmacodynamics of these drugs can vary significantly between horses and other species, necessitating careful consideration of dosage and administration methods. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, safety, and regulatory aspects of pharmaceuticals used in equine healthcare.
In vitro phase I metabolism of selective estrogen receptor modulators in horse using ultra-high performance liquid chromatography-high resolution mass spectrometry.
Drug testing and analysis    February 16, 2017   Volume 9, Issue 9 1349-1362 doi: 10.1002/dta.2158
Kwok KY, Chan GHM, Kwok WH, Wong JKY, Wan TSM.Selective estrogen receptor modulators (SERMs) are chemicals that possess the anti-oestrogenic activities that are banned 'in' and 'out' of competition by the World Anti-Doping Agency (WADA) in human sports, and by the International Federation of Horseracing Authorities (IFHA) in horseracing. SERMs can be used as performance-enhancing drugs to boost the level of androgens or to compensate for the adverse effects as a result of extensive use of androgenic anabolic steroids (AASs). SERMs have indeed been abused in human sports; hence, a similar threat can be envisaged in horseracing. Numerous an...
Screening of over 100 drugs in horse urine using automated on-line solid-phase extraction coupled to liquid chromatography-high resolution mass spectrometry for doping control.
Journal of chromatography. A    February 14, 2017   Volume 1490 89-101 doi: 10.1016/j.chroma.2017.02.020
Kwok WH, Choi TLS, Tsoi YYK, Leung GNW, Wan TSM.A fast method for the direct analysis of enzyme-hydrolysed horse urine using an automated on-line solid-phase extraction (SPE) coupled to a liquid-chromatography/high resolution mass spectrometer was developed. Over 100 drugs of diverse drug classes could be simultaneously detected in horse urine at sub to low parts per billion levels. Urine sample was first hydrolysed by β-glucuronidase to release conjugated drugs, followed by centrifugal filtration. The filtrate (1mL) was directly injected into an on-line SPE system consisting of a pre-column filter and a SPE cartridge column for the separa...
Therapeutics for Equine Endocrine Disorders.
The Veterinary clinics of North America. Equine practice    February 9, 2017   Volume 33, Issue 1 127-139 doi: 10.1016/j.cveq.2016.11.003
Durham AE.Equine endocrine disease is commonly encountered by equine practitioners. Pituitary pars intermedia dysfunction (PPID) and equine metabolic syndrome (EMS) predominate. The most logical therapeutic approach in PPID uses dopamine agonists; pergolide mesylate is the most common. Bromocryptine and cabergoline are alternative drugs with similar actions. Drugs from other classes have a poor evidence basis, although cyproheptadine and trilostane might be considered. EMS requires management changes as the primary approach; reasonable justification for use of drugs such as levothyroxine and metformin m...
Influence of respiratory tract disease and mode of inhalation on detectability of budesonide in equine urine and plasma.
American journal of veterinary research    February 1, 2017   Volume 78, Issue 2 244-250 doi: 10.2460/ajvr.78.2.244
Barton AK, Heinemann H, Schenk I, Machnik M, Gehlen H.OBJECTIVE To evaluate the influence of respiratory tract disease (ie, recurrent airway obstruction [RAO]) and mode of inhalation on detectability of inhaled budesonide in equine plasma and urine samples. ANIMALS 16 horses (8 healthy control horses and 8 horses affected by RAO, as determined by results of clinical examination, blood gas analysis, bronchoscopy, and cytologic examination of bronchoalveolar lavage fluid). PROCEDURES 4 horses of each group inhaled budesonide (3 μg/kg) twice daily for 10 days while at rest, and the remaining 4 horses of each group inhaled budesonide during lunging ...
The Analysis of Phenylbutazone and Its Active Metabolite, Oxyphenbutazone, in Equine Tissues (Muscle, Kidney, and Liver), Urine, and Serum by LC-MS/MS.
Journal of AOAC International    February 1, 2017   Volume 100, Issue 4 1110-1122 doi: 10.5740/jaoacint.16-0127
Boison JO, Dowling P, Matus JL, Kinar J, Johnson R.This study reports the use of two validated LC with tandem MS (MS/MS) methods to study the residue depletion profile of phenylbutazone (PBZ) and its metabolite oxyphenbutazone (OXPBZ) from equine serum, urine, and muscle, kidney, and liver tissues. One LC-MS/MS method, with an LOQ of 1.0 ng/mL for PBZ and 2.0 ng/mL for OXPBZ, was used for the analysis of the two drugs in the biological fluids (equine urine and serum); the other LC-MS/MS method, with an LOQ of 0.5 ng/g for PBZ and OXPBZ, was used for the analysis of the drugs in the equine tissue samples. PBZ was administered intravenously to t...
Pharmacokinetics and in vitro efficacy of salicylic acid after oral administration of acetylsalicylic acid in horses.
BMC veterinary research    January 19, 2017   Volume 13, Issue 1 28 doi: 10.1186/s12917-017-0955-1
Buntenkötter K, Osmers M, Schenk I, Schänzer W, Machnik M, Düe M, Kietzmann M.Although acetylsalicylic acid (ASA) is not frequently used as a therapeutic agent in horses, its metabolite SA is of special interest in equestrianism since it is a natural component of many plants used as horse feed. This led to the establishment of thresholds by horse sport organizations for SA in urine and plasma. The aim of this study was to investigate plasma and urine concentrations of salicylic acid (SA) after oral administration of three different single dosages (12.5 mg/kg, 25 mg/kg and 50 mg/kg) of acetylsalicylic acid (ASA) to eight horses in a cross-over designed study. Results:...
Effects of xylazine and dexmedetomidine on equine articular chondrocytes in vitro.
Veterinary anaesthesia and analgesia    January 17, 2017   Volume 44, Issue 2 295-308 doi: 10.1016/j.vaa.2016.04.004
Mancini F, Nannarone S, Buratta S, Ferrara G, Stabile AM, Vuerich M, Santinelli I, Pistilli A, Chiaradia E.To assess the effects of xylazine and dexmedetomidine on equine chondrocytes, in vitro. Methods: Prospective, experimental study. Methods: Equine articular chondrocytes from five male horses. Methods: Chondrocytes were isolated from healthy equine articular cartilage of the metacarpo/metatarsophalangeal joints. Cell viability was assessed using the WST-8 assay by exposing chondrocytes to xylazine (0.5, 1, 2, 4, 8, 16.6, 25, 50 mg mL) or dexmedetomidine (0.001, 0.005, 0.01, 0.05, 0.175, 0.25 mg mL) for 15, 30 and 60 minutes. Based on the results of these tests, cells were treated with xyla...
Pharmacokinetics of intravenous continuous rate infusions of sodium benzylpenicillin and ceftiofur sodium in adult horses.
American journal of veterinary research    December 29, 2016   Volume 78, Issue 1 17-26 doi: 10.2460/ajvr.78.1.17
Edwards SH, Khalfan SA, Jacobson GA, Pirie AD, Raidal SL.OBJECTIVE To determine plasma drug concentrations after IV administration of a bolus followed by continuous rate infusion (CRI) of sodium benzylpenicillin and ceftiofur sodium to healthy adult horses. ANIMALS 6 Thoroughbred mares (3 to 9 years old; mean ± SD body weight, 544 ± 55 kg) with no history of recent antimicrobial treatment. PROCEDURES Horses were used in 2 experiments conducted 14 days apart. For each experiment, horses were housed individually in stables, and catheters were placed bilaterally in both jugular veins for drug administration by CRI (left catheter) and for intermittent...
Pharmacokinetics and tolerability of a new formulation of omeprazole in the horse.
Journal of veterinary pharmacology and therapeutics    November 24, 2016   Volume 40, Issue 4 348-355 doi: 10.1111/jvp.12371
Di Salvo A, Busechian S, Zappulla F, Marchesi MC, Pieramati C, Orvieto S, Boveri M, Predieri PG, Rueca F, Della Rocca G.A new formulation of omeprazole in gastro-resistant granules was tested with regard to its pharmacokinetics and tolerability. Twenty-four horses were randomly divided into three groups (8 horses/group) and treated, according a parallel study design, as follows: Group A untreated (control group), Group B received 4 mg/kg of omeprazole, and Group C received 12 mg/kg of omeprazole, both of which were treated orally once a day for 90 days. Blood samples, taken from Group B subjects during the 1st and the 29th day of treatment at pre-established time points, were used to determine the concentrat...
Validation of a method for sedatives and β-blockers determination in swine, bovine and equine kidney using liquid chromatography coupled with tandem mass spectrometry.
Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment    November 21, 2016   Volume 34, Issue 1 32-39 doi: 10.1080/19440049.2016.1252468
de Oliveira LG, Barreto F, Hoff R, Rübensam G, Scherer Kurz MH, Galle G, Gonçalves FF.A method for the determination of five sedatives and 14 β-blocker residues in swine, bovine and equine kidney was validated. Samples were extracted with acetonitrile and purified using dispersive solid phase extraction (d-SPE) with Celite 545 with subsequent analysis by LC-MS/MS. A simplified protocol was applied to validate the method scope extension to include new matrices. Parameters such as recovery, trueness, linearity (r), relative standard deviation (RSD), decision limit (CCα) and method capability (CCβ) were measured for the bovine and equine kidney matrices. The method was applied ...
Evaluation of xylazine and ketamine for maintenance of anesthesia in horses.
Veterinary anaesthesia and analgesia    November 16, 2016   Volume 27, Issue 2 105 doi: 10.1016/S1467-2987(16)31355-1
Mama KR, Wagner AE, Steffey EP, Kollias-Baker C, Hellyer PW, Golden AE, Brevard LF.Eight horses [5.6 ± 3.6 years, 489 ± 48.6 kg (mean ± SD)] were anesthetized four times under laboratory conditions to characterize physiologic and behavioral (reported elsewhere) responses associated with a 1-hours period of total intravenous anesthesia (TIA). Each horse was premedicated with xylazine (X, 0.75 mg kg−1) and anesthesia induced 5 minutes later with 5% guaifenesin (75 mg kg−1) and ketamine (K, 2 mg kg−1), all given IV After anesthetic induction, horses were intubated and received one of six treatments [X 35, K 90, O2; X 35, K 120, O2; X 35, K 120, air; X 35, K150, O2; X 7...
Evaluation of xylazine, butorphanol and propofol for short-term intravenous anesthesia in horses.
Veterinary anaesthesia and analgesia    November 15, 2016   Volume 29, Issue 2 106 doi: 10.1046/j.1467-2995.2002.00078_22.x
Garcia Lascurain AA, Sumano Lopez H, Steffey EP, Santillan Doherty P, Nuñez Hernandez E.No abstract available
Urinary effects of xylazine and general anesthesia in horses.
Veterinary anaesthesia and analgesia    November 15, 2016   Volume 29, Issue 2 107 doi: 10.1046/j.1467-2995.2002.00078_25.x
Watson ZE, Steffey EP, Van Hoogmoed LM, Snyder JR.No abstract available
Shortened egg reappearance after ivermectin or moxidectin use in horses in the UK.
Veterinary journal (London, England : 1997)    November 14, 2016   Volume 218 36-39 doi: 10.1016/j.tvjl.2016.11.003
Daniels SP, Proudman CJ.This study reports ivermectin and moxidectin egg reappearance periods (ERP) from UK horses with persistently positive faecal egg counts (FEC), defined as positive FEC within the ERP of an anthelmintic post-treatment, or with FECs that remained positive after the normal ERP post-anthelmintic treatment. A selected population of UK pleasure horses deemed at high risk of strongyle infection was studied. The earliest ERP recorded after ivermectin or moxidectin, using first positive FEC, was 5 weeks. From 16 premises where moxidectin was used, five had ERP ≥12 weeks using two further metrics. For ...
[Vigilance for veterinary medicinal products: Reports of adverse reactions in the year 2015].
Schweizer Archiv fur Tierheilkunde    November 9, 2016   Volume 158, Issue 11 743-747 doi: 10.17236/sat00090
Müntener C, Kupper J, Naegeli H, Gassner B.A total of 292 adverse reactions to veterinary medicinal products were reported during the year 2015. This represents an increase of 9% compared to the previous year (268 reports). Similar to previous years, most of the reactions reported were linked to the use of antiparasitics (55.1%), non-steroidal anti-inflammatory products (8.9%) or antiinfectives (9.3%). The affected animal species were primarily dogs (198 reports) and cats (42 reports), followed by cattle (31 reports) and horses (8 reports). Additional 42 reports were provided within the frame of consultations with Tox Info Suisse in ZÃ...
Quantification of dimethylsulfoxide (DMSO) in equine plasma and urine using HILIC-MS/MS.
Drug testing and analysis    November 4, 2016   Volume 9, Issue 6 935-941 doi: 10.1002/dta.2098
Salomonsson ML, Bondesson U, Hedeland M.This paper describes quantitative methods for the determination of dimethylsulfoxide (DMSO) in equine plasma and urine based on simple precipitation and dilution followed by hydrophilic interaction liquid chromatography coupled to tandem mass spectrometry (HILIC-MS/MS). DMSO is a polar solvent with analgesic and anti-inflammatory properties. Its pharmacological features make it prohibited in horse racing. However, since DMSO is naturally present in the horses' environment, international threshold values have been implemented for plasma and urine (1 and 15 µg/mL, respectively). Previously pr...
Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study.
Veterinary ophthalmology    October 28, 2016   Volume 20, Issue 5 398-404 doi: 10.1111/vop.12439
Tofflemire K, Whitley EM, Allbaugh R, Ben-Shlomo G, Griggs A, Strong T, Whitley RD.To evaluate the effect of topical ophthalmic 0.005% latanoprost alone and in combination with 0.1% diclofenac on healthy horses. Methods: Twelve healthy adult horses. Methods: A randomized, masked crossover design was used with horses divided into three groups for once daily treatment in one randomly selected eye. For arm 1 of the study, Group D (n = 3) received 0.1% diclofenac, Group L (n = 3) received 0.005% latanoprost, and Group DL (n = 6) received 0.005% latanoprost and 0.2 ml of 0.1% diclofenac. For arm 2 of the study, horses from Group D and L were placed into Group DL and horses from G...
Equine antibiotic recalled.
The Veterinary record    October 23, 2016   Volume 179, Issue 16 394 doi: 10.1136/vr.i5622
No abstract available
Evaluation of an oral direct factor Xa inhibitor anticoagulant in healthy adult horses.
Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)    October 6, 2016   Volume 27, Issue 1 82-88 doi: 10.1111/vec.12540
Rodríguez-Pozo ML, Armengou L, Monreal L, Viu J, Cesarini C, Jose-Cunilleras E.To assess whether an oral direct factor Xa inhibitor (DiXaI) anticoagulant drug used at the low end of the recommended dose in people achieves presumed prophylactic plasma concentrations and does not induce bleeding in horses. Methods: Experimental study. Methods: Field study. Methods: Ten healthy adult horses. Methods: A DiXaI was administered at a dose of 0.125 mg/kg every 24 h orally for 4 days. Following a wash-out period of 2 weeks, 8 of 10 horses received daily subcutaneous doses of a low molecular weight heparin (dalteparin) for 4 consecutive days at 50 IU/kg. In both trials, antifactor...
Doping control analysis of anabolic steroids in equine urine by gas chromatography-tandem mass spectrometry.
Drug testing and analysis    October 5, 2016   Volume 9, Issue 9 1320-1327 doi: 10.1002/dta.2090
Wong ASY, Leung GNW, Leung DKK, Wan TSM.Anabolic steroids are banned substances in equine sports. Gas chromatography-mass spectrometry (GC-MS) has been the traditional technique for doping control analysis of anabolic steroids in biological samples. Although liquid chromatography-mass spectrometry (LC/MS) has become an important technique in doping control, the detection of saturated hydroxysteroids by LC-MS remains a problem due to their low ionization efficiency under electrospray. The recent development in fast-scanning gas-chromatography-triple-quadrupole mass spectrometry (GC-MS/MS) has provided a better alternative with a sign...
Confirmatory analysis of etanercept in equine plasma by LC-MS for doping control.
Drug testing and analysis    October 5, 2016   Volume 9, Issue 9 1421-1431 doi: 10.1002/dta.2091
Guan F, Robinson MA, Soma LR.Etanercept is a protein-based medication for the treatment of human patients with rheumatoid arthritis and other autoimmune-based diseases; its pharmacological action is to inhibit and antagonize tumour necrosis factor alpha. Etanercept was rumoured to be used in horse racing in North America. To detect such use, the aim of this study was to develop a liquid chromatography-mass spectrometry (LC-MS) method for confirmation of etanercept in equine plasma. Etanercept was extracted from plasma by anti-human IgG antibody linked to magnetic beads. The analyte was reduced and alkylated, and then dige...
Pharmacokinetics of dextromethorphan and its metabolites in horses following a single oral administration.
Drug testing and analysis    October 3, 2016   Volume 9, Issue 6 880-887 doi: 10.1002/dta.2060
Corado CR, McKemie DS, Knych HK.Dextromethorphan is an N-methyl-D-aspartate (NMDA) non-competitive antagonist commonly used in human medicine as an antitussive. Dextromethorphan is metabolized in humans by cytochrome P450 2D6 into dextrorphan, which is reported to be more potent than the parent compound. The goal of this study is to describe the metabolism of and determine the pharmacokinetics of dextromethorphan and its major metabolites following oral administration to horses. A total of 23 horses received a single oral dose of 2 mg/kg. Blood samples were collected at time 0 and at various times up to 96 h post drug ad...
Equine hepatocytes: isolation, cryopreservation, and applications to in vitro drug metabolism studies.
Pharmacology research & perspectives    September 30, 2016   Volume 4, Issue 5 e00268 doi: 10.1002/prp2.268
Shibany KA, Tötemeyer S, Pratt SL, Paine SW.Despite reports of the successful isolation of primary equine hepatocytes, there are no published data regarding the successful cryopreservation of these isolated cells. In this study, a detailed description of the procedures for isolation, cryopreservation, and recovery of equine hepatocytes are presented. Furthermore, the intrinsic clearance (Cl) and production of metabolites for three drugs were compared between freshly isolated and recovered cryopreserved hepatocytes. Primary equine hepatocytes were isolated using a two-step collagenase perfusion method, with an average cell yield of 2.47Â...
Pharmacokinetic profiles of the active metamizole metabolites in healthy horses.
Journal of veterinary pharmacology and therapeutics    July 31, 2016   Volume 40, Issue 2 165-171 doi: 10.1111/jvp.12342
Giorgi M, Aupanun S, Lee HK, Poapolathep A, Rychshanova R, Vullo C, Faillace V, Laus F.Metamizole (MT) is an analgesic and antipyretic drug labelled for use in humans, horses, cattle, swine and dogs. MT is rapidly hydrolysed to the active primary metabolite 4-methylaminoantipyrine (MAA). MAA is formed in much larger amounts compared with other minor metabolites. Among the other secondary metabolites, 4-aminoantipyrine (AA) is also relatively active. The aim of this research was to evaluate the pharmacokinetic profiles of MAA and AA after dose of 25 mg/kg MT by intravenous (i.v.) and intramuscular (i.m.) routes in healthy horses. Six horses were randomly allocated to two equally...
Analysis of phenylbutazone residues in horse tissues with and without enzyme-hydrolysis by LC-MS/MS.
Drug testing and analysis    July 23, 2016   Volume 8, Issue 5-6 535-538 doi: 10.1002/dta.2020
Boison JO, Dowling T, Johnson R, Kinar J.Phenylbutazone (PBZ) is permitted to be used for the treatment of musculoskeletal pain and inflammation in race horses but it is not approved for use in horses destined for human consumption. In a recent study initiated in our laboratory to study the disposition of PBZ and its oxyphenbutazone (OXPBZ) metabolite in equine tissues, we compared the effect of an additional enzymatic hydrolysis step with ß-glucuronidase on the results of the analysis for PBZ without enzymatic hydrolysis. Incurred tissue samples obtained from a female horse dosed with PBZ at 8.8 mg/kg for 3 days and sacrificed ...
In vitro analysis of the effect of supplementation with activated charcoal on the equine hindgut.
Journal of equine science    June 21, 2016   Volume 27, Issue 2 49-55 doi: 10.1294/jes.27.49
Edmunds JL, Worgan HJ, Dougal K, Girdwood SE, Douglas JL, McEwan NR.The present study uses in vitro analytical techniques to investigate the effect of activated charcoal on the microbial community of the equine hindgut and the metabolites they produce. Incubations were performed in Wheaton bottles using a 50 ml incubation of a high-energy feed or a low-energy feed, plus bottles with no added food source, together with five levels of activated charcoal (0, 10, 25, 50 or 100 mg per bottle) and fecal samples as a bacterial inoculum. Using this method the rate of gas production, volatile fatty acid and ammonia concentrations, and pH values were analyzed and found ...
Long-term monitoring of opioid, sedative and anti-inflammatory drugs in horse hair using a selective and sensitive LC-MS/MS procedure.
BMC veterinary research    June 1, 2016   Volume 12 84 doi: 10.1186/s12917-016-0709-5
Madry MM, Spycher BS, Kupper J, Fuerst A, Baumgartner MR, Kraemer T, Naegeli H.Compared to blood or urine, drugs can be detected for much longer periods in the long hair of horses. The aim of this study was to establish and validate a highly sensitive liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the detection and quantification of frequently prescribed opioids, sedatives and non-steroidal anti-inflammatory agents in the mane and tail hair of horses. Based on an average growth rate of about 2 cm per month, times of administration reported by horse owners or veterinary physicians were related to drug localizations in hair. Hair samples were collecte...
[New drugs for horses and production animals in 2015].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    May 24, 2016   Volume 44, Issue 3 164-170 doi: 10.15653/TPG-160400
Emmerich IU.In 2015, four newly developed active pharmaceutical ingredients for horses and food-producing animals were released on the German market for veterinary drug products. These were the bisphosphonate Clodronic Acid (Osphos®), the 5-hydroxytryptamine (2A) receptor antagonist Ketanserin (Vulketan®), the aminoglycoside antibiotic Paromomycin (Parofor®) and the antibiotic Thiamphenicol (TAF Spray®) from the fenicole group. With Chlorphenamine, a temporary not available active ingredient was reapproved in a new drug. Furthermore, three veterinary drugs with a new formulation as well as one product...
Doping control analysis of 46 polar drugs in horse plasma and urine using a ‘dilute-and-shoot’ ultra high performance liquid chromatography-high resolution mass spectrometry approach.
Journal of chromatography. A    May 3, 2016   Volume 1451 41-49 doi: 10.1016/j.chroma.2016.05.002
Kwok WH, Choi TLS, Kwok KY, Chan GHM, Wong JKY, Wan TSM.The high sensitivity of ultra high performance liquid chromatography coupled with high resolution mass spectrometry (UHPLC-HRMS) allows the identification of many prohibited substances without pre-concentration, leading to the development of simple and fast 'dilute-and-shoot' methods for doping control for human and equine sports. While the detection of polar drugs in plasma and urine is difficult using liquid-liquid or solid-phase extraction as these substances are poorly extracted, the 'dilute-and-shoot' approach is plausible. This paper describes a 'dilute-and-shoot' UHPLC-HRMS screening me...
Elimination of cetirizine following administration of multiple doses to exercised thoroughbred horses.
Journal of veterinary pharmacology and therapeutics    April 28, 2016   Volume 39, Issue 5 522-524 doi: 10.1111/jvp.12318
Knych HK, Stanley SD, Arthur RM, McKemie DS.Cetirizine is an antihistamine used in performance horses for the treatment of hypersensitivity reactions and as such a withdrawal time is necessary prior to competition. The objective of the current study was to describe the disposition and elimination of cetirizine following oral administration in order to provide additional serum concentration data upon which appropriate regulatory recommendations can be established. Nine exercised thoroughbred horses were administered 0.4 mg/kg of cetirizine orally BID for a total of five doses. Blood samples were collected immediately prior to drug admin...
1 5 6 7 8 9 36